Simplex Trading
CLSD

Simplex Trading’s Clearside Biomedical CLSD Stock Holding History

Simplex Trading’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8
Closed – – 9167
2025
Q2 		$0 Buy
+8
New +$99 ﹤0.01% 8759
2024
Q4 		– Sell
-295
Closed -$4.85K – 8623
2024
Q3 		$5K Sell
295
-147
-33% -$2.51K ﹤0.01% 7585
2024
Q2 		$8K Buy
442
+87
+25% +$1.68K ﹤0.01% 7558
2024
Q1 		$8K Sell
355
-411
-54% -$8.86K ﹤0.01% 7733
2023
Q4 		$13K Buy
766
+443
+137% +$6.32K ﹤0.01% 7232
2023
Q3 		$4K Buy
323
+178
+123% +$2.69K ﹤0.01% 7738
2023
Q2 		$2K Buy
+145
New +$2.5K ﹤0.01% 8380
2022
Q4 		– Sell
-1,631
Closed -$29.4K – 9320
2022
Q3 		$27K Sell
1,631
-133
-8% -$2.91K ﹤0.01% 7179
2022
Q2 		$38K Buy
1,764
+1,218
+223% +$29.6K ﹤0.01% 6840
2022
Q1 		$18K Buy
546
+145
+36% +$4.34K ﹤0.01% 8345
2021
Q4 		$16K Buy
+401
New +$26K ﹤0.01% 8602
2021
Q1 		– Sell
-307
Closed -$15.4K – 8937
2020
Q4 		$0 Buy
+307
New +$7.96K ﹤0.01% 8402
2020
Q3 		– Sell
-934
Closed -$24.1K – 7847
2020
Q2 		$26K Sell
934
-73
-7% -$2.15K ﹤0.01% 6010
2020
Q1 		$25K Sell
1,007
-4,051
-80% -$150K ﹤0.01% 5760
2019
Q4 		$220K Buy
5,058
+5,028
+16,760% +$106K ﹤0.01% 3649
2019
Q3 		$0 Sell
30
-1
-3% -$14 ﹤0.01% 7295
2019
Q2 		$0 Buy
+31
New +$553 ﹤0.01% 7166
2019
Q1 		– Sell
-243
Closed -$4.82K – 7189
2018
Q4 		$3K Sell
243
-92
-27% -$4.32K ﹤0.01% 6403
2018
Q3 		$30K Sell
335
-1,589
-83% -$189K ﹤0.01% 5635
2018
Q2 		$308K Buy
+1,924
New +$324K ﹤0.01% 2984

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading's CLSD Position: Q3 2025 in Review

Simplex Trading sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 8 shares.

Simplex Trading first reported a position in CLSD in Q2 2018 and held it in 20 quarters. The position peaked at $308K in Q2 2018. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Simplex Trading reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 8 Clearside Biomedical shares in Q3 2025.
  • Simplex Trading first reported a position in Clearside Biomedical in Q2 2018 and held it in 20 quarters.
  • Simplex Trading's Clearside Biomedical position peaked at $308K in Q2 2018.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.